Corpus ID: 28542908

[Ifosfamide chemotherapy ineffective for advanced pancreatic carcinoma].

  title={[Ifosfamide chemotherapy ineffective for advanced pancreatic carcinoma].},
  author={T. Fujiki and K. Futatsuki and S. Akazawa and K. Yamamoto and Y. Kanda and A. Yamato and K. Terashi and Y. Suda},
  journal={Gan to kagaku ryoho. Cancer & chemotherapy},
  volume={24 5},
  • T. Fujiki, K. Futatsuki, +5 authors Y. Suda
  • Published 1997
  • Medicine
  • Gan to kagaku ryoho. Cancer & chemotherapy
  • Ifosfamide chemotherapy was studied in 20 patients with advanced pancreatic carcinoma. It was administered at a dose of 1.2-1.5 g/body/day for 5 consecutive days every 3-4 weeks, and the patients treated over 2 courses were registered in our trial. Eleven patients had not received prior chemotherapy. Results achieved were as follows: PR in one patient, NC in 9 patients, and PD in 10 patients. The response rate was 5% and the median survival time was 17 weeks. Toxic effects included anorexia (80… CONTINUE READING
    4 Citations